Slides and Webcasts from all ESMO Advanced Courses are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.
ESMO Advanced Course on ADC Development, Therapeutic Applications and Research: Thoracic and Genitourinary Cancers 2024: Zurich
- Start date
- 25 Nov 2024
- End date
- 26 Nov 2024
- Location
- Zurich, Switzerland
Learning objectives
- To provide insights on ADCs drug development
- To explain mechanism of action of the most common ADCs used in clinical practice
- To highlight the integration of ADCs in current clinical practice guidelines across pathologies
- To provide guidance on management of toxicities of ADCs
Co-Chairs
- Solange Peters, Switzerland
- Thomas Powles, United Kingdom
Travel grant
In addition to the course registration and the hotel accommodation, a travel grant of maximum 600 euros is offered to non-local participants as a contribution versus their travel costs (excluding Visa costs).
Participants must supply proof of travel as appropriate (tickets and receipts/invoices).
The reimbursement will be processed after the course according to the rules below:
Distance |
Reimbursement per return trip |
---|---|
Up to 100 km |
EUR 70.00 |
101 > 399 km |
EUR 150.00 |
> 400 km |
Please visit this page and use the rail or flight calculator by inserting the city of departure and the city of arrival; then refer to Table 2 (on the same page) to check the reimbursement amount corresponding to the calculated distance. |
*Place of work |
Accreditation
The programme of this event has been accredited with 9 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.